|
1.
|
Zouboulis CC: Acne and sebaceous gland
function. Clin Dermatol. 22:360–366. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Plewig G: How acne vulgaris develops.
Hautarzt. 61:99–100. 106(In German).
|
|
3.
|
McDonald SK, Goh MS and Chong AH:
Successful treatment of cyclosporine-induced sebaceous hyperplasia
with oral isotretinoin in two renal transplant recipients.
Australas J Dermatol. 52:227–230. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Orfanos CE and Zouboulis CC: Oral
retinoids in the treatment of seborrhoea and acne. Dermatology.
196:140–147. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Doran TI and Shapiro SS: Retinoid effects
on sebocyte proliferation. Methods Enzymol. 190:334–338. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
De Marchi MA, Maranhão RC, Brandizzi LI
and Souza DR: Effects of isotretinoin on the metabolism of
triglyceride-rich lipoproteins and on the lipid profile in patients
with acne. Arch Dermatol Res. 297:403–408. 2006.PubMed/NCBI
|
|
7.
|
Wong A, Williams M and Gibb W:
Isotretinoin-induced encephalopathy. J Dermatolog Treat.
21:361–362. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Yaman M, Albayram S, Altintas A, et al: A
cerebellar demyelinating lesion following treatment of acne with
isotretinoin. Clin Exp Dermatol. 33:118–121. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Tinoco MP, Tamler C, Maciel G, et al:
Pyoderma gangrenosum following isotretinoin therapy for acne
nodulocystic. Int J Dermatol. 47:953–956. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Papageorgiou NP, Altman A and Shoenfeld Y:
Inflammatory bowel disease: adverse effect of isotretinoin. Isr Med
Assoc J. 11:505–506. 2009.PubMed/NCBI
|
|
11.
|
Malvasi A, Tinelli A, Buia A and De Luca
GF: Possible long-term teratogenic effect of isotretinoin in
pregnancy. Eur Rev Med Pharmacol Sci. 13:393–396. 2009.PubMed/NCBI
|
|
12.
|
Azoulay L, Blais L, Koren G, et al:
Isotretinoin and the risk of depression in patients with acne
vulgaris: a case-crossover study. J Clin Psychiatry. 69:526–532.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Gao YG, Wang LZ and Tang JX: Sex
hormone-like activity of Tanshinone (author's transl). Zhongguo Yi
Xue Ke Xue Yuan Xue Bao. 2:189–191. 1980.(In Chinese).
|
|
14.
|
Wang DB and Liu AS: Tanshinone in the
treatment of acne (a primary report of 20 cases) (author’s transl).
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2:187–188. 1980.(In
Chinese).
|
|
15.
|
Wang DB: Tanshinone in the treatment of
acne. J Tradit Chin Med. 3:227–228. 1983.PubMed/NCBI
|
|
16.
|
Hei M, Luo Y, Zhang X and Liu F:
Tanshinone IIa alleviates the biochemical changes associated with
hypoxic ischemic brain damage in a rat model. Phytother Res.
25:1865–1869. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Tan X, Li J, Wang X, et al: Tanshinone IIA
protects against cardiac hypertrophy via inhibiting
calcineurin/NFATc3 pathway. Int J Biol Sci. 7:383–389. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Cheng CY and Su CC: Tanshinone IIA may
inhibit the growth of small cell lung cancer H146 cells by
up-regulating the Bax/Bcl-2 ratio and decreasing mitochondrial
membrane potential. Mol Med Report. 3:645–650. 2010.PubMed/NCBI
|
|
19.
|
Bian Z, Li LM, Tang R, et al:
Identification of mouse liver mitochondria-associated miRNAs and
their potential biological functions. Cell Res. 20:1076–1078. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Dong X, Dong J, Zhang R, et al:
Anti-inflammatory effects of tanshinone IIA on radiation-induced
microglia BV-2 cells inflammatory response. Cancer Biother
Radiopharm. 24:681–687. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Lin R, Wang WR, Liu JT, et al: Protective
effect of tanshinone IIA on human umbilical vein endothelial cell
injured by hydrogen peroxide and its mechanism. J Ethnopharmacol.
108:217–222. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Qiang J, Xingping Y, Jihai S, et al:
Effects of Cryptotanshinone and Tanshinone A on proliferation,
lipid synthesis and expression of androgen receptor mRNA in human
sebocytes in vitro. Chin J Dermatol. 38:98–101. 2005.(In
Chinese).
|
|
23.
|
Huang Q, Zhou B, Guo X, et al:
Sulfotanshinone sodium suppresses sebaceous hyperplasia in Syrian
hamsters. Chin J Dermatol. 44:643–645. 2011.(In Chinese).
|
|
24.
|
Horton JD and Shimomura I: Sterol
regulatory element-binding proteins: activators of cholesterol and
fatty acid biosynthesis. Curr Opin Lipidol. 10:143–150. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Shimano H: Sterol regulatory
element-binding proteins (SREBPs): transcriptional regulators of
lipid synthetic genes. Prog Lipid Res. 40:439–452. 2001. View Article : Google Scholar
|
|
26.
|
Eberlé D, Hegarty B, Bossard P, et al:
SREBP transcription factors: master regulators of lipid
homeostasis. Biochimie. 86:839–848. 2004.PubMed/NCBI
|
|
27.
|
Rosignoli C, Nicolas JC, Jomard A and
Michel S: Involvement of the SREBP pathway in the mode of action of
androgens in sebaceous glands in vivo. Exp Dermatol. 12:480–489.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Harrison WJ, Bull JJ, Seltmann H, et al:
Expression of lipogenic factors galectin-12, resistin, SREBP-1, and
SCD in human sebaceous glands and cultured sebocytes. J Invest
Dermatol. 127:1309–1317. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Smith TM, Gilliland K, Clawson GA and
Thiboutot D: IGF-1 induces SREBP-1 expression and lipogenesis in
SEB-1 sebocytes via activation of the phosphoinositide 3-kinase/Akt
pathway. J Invest Dermatol. 128:1286–1293. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Chang Y, Wang J, Lu X, et al: KGF induces
lipogenic genes through a PI3K and JNK/SREBP-1 pathway in H292
cells. J Lipid Res. 46:2624–2635. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Hao J, Liu S, Zhao S, et al: PI3K/Akt
pathway mediates high glucose-induced lipogenesis and extracellular
matrix accumulation in HKC cells through regulation of SREBP-1 and
TGF-β1. Histochem Cell Biol. 135:173–181. 2011.PubMed/NCBI
|
|
32.
|
Yang YA, Han WF, Morin PJ, et al:
Activation of fatty acid synthesis during neoplastic
transformation: role of mitogen-activated protein kinase and
phosphatidylinositol 3-kinase. Exp Cell Res. 279:80–90. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Du X, Kristiana I, Wong J and Brown AJ:
Involvement of Akt in ER-to-Golgi transport of SCAP/SREBP: a link
between a key cell proliferative pathway and membrane synthesis.
Mol Biol Cell. 17:2735–2745. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Porstmann T, Griffiths B, Chung YL, et al:
PKB/Akt induces transcription of enzymes involved in cholesterol
and fatty acid biosynthesis via activation of SREBP. Oncogene.
24:6465–6481. 2005.PubMed/NCBI
|
